Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenue from awards and licenses $ 136,558 $ 286,346 $ 784,382 $ 2,048,405
Operating expenses:        
Research and development 11,265,220 30,686,071 21,986,043 54,633,937
General and administrative 5,572,397 7,738,968 10,913,594 15,438,447
Total operating expenses 16,837,617 38,425,039 32,899,637 70,072,384
Operating loss (16,701,059) (38,138,693) (32,115,255) (68,023,979)
Other income (expense), net:        
Other income (expense), net (227,609) (242,703)  
Interest income (expense), net (401,170) 12,649 (1,047,720) 114,642
Change in fair value of derivative liability 204,000 198,000
Foreign currency exchange gain (loss), net (12,538) 20,721 4,134 147,214
Other income (expense), net (437,317) 33,370 (1,088,289) 261,856
Net loss $ (17,138,376) $ (38,105,323) $ (33,203,544) $ (67,762,123)
Net loss per share, basic and diluted $ (0.15) $ (0.52) $ (0.28) $ (0.95)
Weighted average number of common shares outstanding, basic and diluted 116,364,131 73,885,548 120,722,622 71,578,975
Comprehensive loss:        
Net loss $ (17,138,376) $ (38,105,323) $ (33,203,544) $ (67,762,123)
Other comprehensive income (loss):        
Unrealized gain (loss) on marketable debt securities 23,311 (5,454)
Total other comprehensive income (loss) 23,311 (5,454)
Total comprehensive loss $ (17,115,065) $ (38,105,323) $ (33,208,998) $ (67,762,123)